Healthcare provider profile · identity verified

Michael Wilson, MD

Family Practice · ANDOVER, KS · NPI 1255340337

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	187
Levothyroxine Sodium	Levothyroxine Sodium	387	96
Amlodipine Besylate	Amlodipine Besylate	347	89
Losartan Potassium	Losartan Potassium	321	86
Omeprazole	Omeprazole	283	76
Pantoprazole Sodium	Pantoprazole Sodium	277	78
Tamsulosin Hcl	Tamsulosin Hcl	255	70
Simvastatin	Simvastatin	236	64
Gabapentin	Gabapentin	230	62
Hydrochlorothiazide	Hydrochlorothiazide	205	56
Tramadol Hcl	Tramadol Hcl	185	35
Metformin Hcl	Metformin Hcl	157	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	30
Alprazolam	Alprazolam	144	29
Lisinopril	Lisinopril	144	40
Olmesartan Medoxomil	Olmesartan Medoxomil	136	40
Citalopram Hbr	Citalopram Hydrobromide	128	34
Ozempic	Semaglutide	109	14
Potassium Chloride	Potassium Chloride	109	31
Meloxicam	Meloxicam	107	29
Furosemide	Furosemide	103	31
Escitalopram Oxalate	Escitalopram Oxalate	102	32
Alendronate Sodium	Alendronate Sodium	95	21
Metoprolol Succinate	Metoprolol Succinate	95	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	37
Montelukast Sodium	Montelukast Sodium	92	26
Zolpidem Tartrate	Zolpidem Tartrate	88	26
Fluoxetine Hcl	Fluoxetine Hcl	81	12
Celecoxib	Celecoxib	79	17
Rosuvastatin Calcium	Rosuvastatin Calcium	74	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	73	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	23
Duloxetine Hcl	Duloxetine Hcl	68	19
Prednisone	Prednisone	64	43
Allopurinol	Allopurinol	63	22
Metoprolol Tartrate	Metoprolol Tartrate	62	22
Oxybutynin Chloride Er	Oxybutynin Chloride	62	13
Donepezil Hcl	Donepezil Hcl	61	17
Clopidogrel	Clopidogrel Bisulfate	60	21
Metformin Hcl Er	Metformin Hcl	59	17
Sertraline Hcl	Sertraline Hcl	58	19
Bupropion Xl	Bupropion Hcl	53	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	15
Estradiol	Estradiol	47	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	11
Carvedilol	Carvedilol	45	15
Pravastatin Sodium	Pravastatin Sodium	42	11
Synthroid	Levothyroxine Sodium	42	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Telmisartan	Telmisartan	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Eliquis	Apixaban	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Clonidine Hcl	Clonidine Hcl	36	11
Chlorthalidone	Chlorthalidone	35	13
Warfarin Sodium	Warfarin Sodium	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	12
Baclofen	Baclofen	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Atenolol	Atenolol	29	suppressed
Cephalexin	Cephalexin	29	24
Famotidine	Famotidine	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Trazodone Hcl	Trazodone Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	16
Ezetimibe	Ezetimibe	24	suppressed
Finasteride	Finasteride	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Primidone	Primidone	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Januvia	Sitagliptin Phosphate	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ramipril	Ramipril	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Linzess	Linaclotide	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error